Filariasis is a group of parasitic infections caused by thread-like nematodes (roundworms) belonging to the Filarioidea superfamily. Lymphatic filariasis, caused by Wuchereria bancrofti, Brugia malayi, and Brugia timori, is a major contributor to the global burden of neglected tropical diseases. The parasites are transmitted through the bites of infected mosquitoes, which deposit larvae into the bloodstream. The larvae mature into adult worms that reside in the lymphatic vessels, leading to chronic lymphatic damage and lymphedema. Clinical manifestations of lymphatic filariasis include swelling of the extremities, scrotal swelling (hydrocele in males), and recurrent skin infections. The diagnosis involves detecting microfilariae in blood samples. Mass drug administration with antifilarial drugs like diethylcarbamazine (DEC) or ivermectin, combined with albendazole, is the primary strategy for controlling and eliminating filariasis. Vector control measures, such as insecticide-treated bed nets and environmental management, also play a crucial role in preventing transmission. Research efforts in roundworm infections focus on developing new antiparasitic drugs, improving diagnostic tools, and exploring novel strategies for vector control. Additionally, public health initiatives aim to integrate filariasis control into broader health programs to achieve sustainable disease elimination.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation